Xue Zhong

Xue Zhong

Auto-generated profile, based on publicly available information

Xue Zhong

Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People’s Republic of China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
XZXue Zhong
Xue Zhong
YXYuanlong Xie
Yuanlong Xie
YCYuen Chen
Yuen Chen
YLYushen Lu
Yushen Lu
MHMingming Hou
Mingming Hou
Peptide-based fluorescent probes have found widespread applications in biomedical research, including bio-imaging, disease diagnosis, drug discovery, and image-guided surgery. Their favorable properties—such as small molecular size, low toxicity, minimal immunogenicity, and high targeting specificity—have contributed to their growing utility in both basic research and translational medicine. This review provides a comprehensive overview of recent advances in peptide-based fluorescent probes, emphasizing design strategies, biological targets, and diverse functional applications. Key areas of focus include the integration of molecular targeting with imaging capabilities, the emergence of multimodal imaging techniques, and the development of activatable probes responsive to specific biological stimuli. Applications are discussed in the context of tumor cell membrane recognition, subcellular organelle targeting, non-cancer disease diagnosis, and detection of both metal ions and non-metal ions. Notably, responsive probes for reactive oxygen species (ROS) and other biologically relevant non-metal ions are also highlighted, underscoring their diagnostic and therapeutic potential. The review also addresses key limitations—such as poor in vivo stability, limited targeting accuracy, and delivery efficiency—and outlines future directions including smart peptide probe platforms, self-reporting systems, and high-throughput screening based on peptide libraries to accelerate next-generation probe development.